Molecular targeted therapy of gynecological malignant
tumors: the development and challenge, from laboratory to clinic

doi:10.1007/s11684-009-0052-3

PDF(274 KB)

Front. Med. ›› 2009, Vol. 3 ›› Issue (3) : 256-264. DOI: 10.1007/s11684-009-0052-3

Research articles

Molecular targeted therapy of gynecological malignant tumors: the development and challenge, from laboratory to clinic

Pengming SUN PhD, MD ¹, Jalid SEHOULI PhD, MD ², Lihui WEI BM ³,

Author information +

History +

Abstract

More and more molecular drugs based on targeted therapy have been utilized in the treatment of gynecologic cancer, especially in ovarian cancer. In this article, we systematically review the current targeted therapeutic trials running in clinic. Large, randomized trials have been conducted in the treatment of ovarian cancer, endometrial cancer and cervical cancer by using small molecule, antisense, mutational gene as well as antibodies. Other planned or ongoing trials currentlytargeted at molecular markers which may play important roles in gynecological carcinogenesis andprogression suggest that combination chemotherapy with molecular targeted therapy will ultimately be an importantoption.

Keywords

target therapy / gynecologic malignant tumors / clinical trail / molecular medicine

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾

Pengming SUN PhD, MD , Jalid SEHOULI PhD, MD , Lihui WEI BM ,. Molecular targeted therapy of gynecological malignant tumors: the development and challenge, from laboratory to clinic. Front. Med., 2009, 3(3): 256‒264 https://doi.org/10.1007/s11684-009-0052-3